Drugs / Danhong Injection
last change Dec 2015 re-read 3 minutes ago

Danhong Injection

Developed for
myocardial infarction
Investigated by
Beijing Bozhiyin T&S Co., Ltd.

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02158559 Mar 2014 → Dec 2015 myocardial infarction Beijing Bozhiyin T&S Co., Ltd. Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Danhong Injection ClinicalTrials.gov intervention name — accepted as the source's own label NCT02158559 ↗
Route Intravenous “injection intravenous drip” NCT02158559 ↗